Advancing Integrative Care
.
Improving Patient Outcomes
Supporting Practice Success
/ Most Recent /
Large Study Provides New Insights into Long Covid
A study of 10,000 Americans, published online in JAMA, may help improve future diagnostics and treatment of long Covid.
Melatonin May Aggravate Bowel Inflammation
A study published in Microorganisms shows that the popular sleep aid can worsen inflammation of the intestine and impair the action of gut microbiota.
A Precision Treatment Approach to Cognitive Decline Using Highly Targeted Genomics
With decades of experimentation and hundreds of clinical trials, there is still no drug that has been developed that has ...
Introduction to the GI-MAP
Diagnostic Solutions Laboratory is pleased to partner with you to bring true ADVANCES in microbial testing. Our commitment to laboratory ...
How to Enhance Vagus Nerve Tone to Support the Gut-Brain Axis: A Guide for Medical Professionals
Optimize Gut-Brain Axis: Enhance Vagus Nerve Tone. Explore evidence-based strategies for improving vagus nerve health and promoting optimal gut-brain axis functioning. Discover deep breathing, exercise, ...
The Vagus Nerve Superhighway: Formation of the Gut Brain Connection
It’s impressive: the wandering 10th cranial, or vagus, nerve is the longest in the human body, stretching from the brainstem to the lowest ...
GI-MAP: What You Need to Know
The GI-MAP (Microbial Assay Plus)® by Diagnostic Solutions Laboratory is a comprehensive stool test that uses quantitative polymerase chain reaction (qPCR) technology ...
Exposure to Hydrocarbons Increases Arthritis Risk
Research published in the journal BMJ Open found that exposure to compounds caused by burning coal, oil, wood, and tobacco can increase risk of developing ...
Inhaling Menthol Improves Cognitive Function in Alzheimer’s Patients
A Spanish study published in the journal Frontiers in Immunology found that smelling menthol modulated immunity and improved cognition in an animal model of Alzheimer’s ...
/ Top Articles /
Sorry, we couldn't find any posts. Please try a different search.
/ Weight Loss /
Stopping GLP-1 Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity. Landmark trials demonstrated significant weight loss in obese individuals. ...
Acknowledging Gender Differences in Obesity Research
With the celebration of International Women’s Day on March 8th, it’s timely to review the differences in women’s health research and how that specifically affects investigations into treatments for overweight and obesity. Obesity and overweight—gender similarities and differences By 2022, 8 billion ...
Researchers Link Abdominal Fat to Brain Health in Men
According to the World Health Organization, some 55 million people globally suffer from Alzheimer’s disease or dementia. With 10 million new cases diagnosed annually, dementia has become the seventh leading cause of death worldwide, and those numbers are only likely to grow ...
Amarasate, An Extract of Bitter Hop Flowers Shown Effective For Weight Loss: The Science And Mode Of Action
With the massive interest in the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the management of both Type 2 diabetes and obesity/overweight, it is timely to review the mode of action of these medications and that of an alternative GLP-1-stimulating nutraceutical. ...
Multiple Human Studies Show Significant Weight-Loss Benefits for Amarasate, A Proprietary Extract of Bitter Hops
A trio of studies performed in the past 5 years shows that a proprietary hops extract called Amarasate can help curb hunger and food cravings.